Finance

Lists
Why is JAZZ up ၂.၆၀%?
Dive Deeper
JAZZ:NASDAQ
Jazz Pharmaceuticals PLC
၂၁၅.၁၁ US$
+၂.၆၀%
(+၅.၄၆) 1D
အောက် ၁၅, GMT-၄ ၁၃:၀၃:၀၂  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for JAZZ...
Open
၂၁၂.၁၉ US$
High
၂၁၇.၅၇ US$
Low
၂၁၂.၁၉ US$
Mkt. cap
ဋေ ၁.၄၀ ထ
Avg. vol.
၇.၈၆ သိန်း
Volume
၄.၂၈ သိန်း
P/E ratio
၁၄.၇၁
52-wk high
၂၆၆.၃၈ US$
52-wk low
၁၂၈.၈၀ US$
EPS
၁၄.၆၃ US$
Beta
၀.၃၇
Shares outstanding
၆.၄၉ ကုဋေ
No. of employees
၃ ထောင်
Open
၂၁၂.၁၉ US$
High
၂၁၇.၅၇ US$
Low
၂၁၂.၁၉ US$
Mkt. cap
ဋေ ၁.၄၀ ထ
Avg. vol.
၇.၈၆ သိန်း
Volume
၄.၂၈ သိန်း
P/E ratio
၁၄.၇၁
52-wk high
၂၆၆.၃၈ US$
52-wk low
၁၂၈.၈၀ US$
EPS
၁၄.၆၃ US$
Beta
၀.၃၇
Shares outstanding
၆.၄၉ ကုဋေ
No. of employees
၃ ထောင်
News stories
From web sources and news partners
Seeking Alpha
Seeking Alpha
·
ပြီးခဲ့သည့် ၄ နာရီ
Jazz Pharmaceuticals: Ziihera And Portfolio Diversification Are Changing The Earnings Story
ad-hoc-news.de
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၆ နာရီ
FDA approves Zepzelca: Jazz Pharmaceuticals stock costs EUR 187.18 with Q2 revenue up 15.50 percent
Profile
Jazz Pharmaceuticals plc is an American global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland. One of the company's considerable products is the United States Food and Drug Administration approved drug Xyrem, the sodium salt of the naturally occurring neurotransmitter γ-Hydroxybutyric acid. In 2017, net product sales of Xyrem were $1.187 billion, which represented 74% of the company's total net product sales. In 2019, Jazz was granted FDA-approval to market Sunosi with indications for treating excessive daytime sleepiness in narcolepsy as well as obstructive sleep apnea. In 2022, it was announced that Axsome Therapeutics would be acquiring Sunosi from Jazz Pharmaceuticals. In 2007, the company pled guilty to felony charges related to its illegal marketing of Xyrem for off-label use. The company is also a member of the Pharmaceutical Research and Manufacturers of America. Wikipedia
About Jazz Pharmaceuticals PLC
CEOBruce C Cozadd
Employees၂.၈၉ ထောင်
Founded၂၀၀၃
Headquarters-
Sector-
Analyst ratings
Based on 18 analysts giving stock ratings to JAZZ in the past 3 months
Strong buy
Buy
17
Hold
1
Sell
0
12-month forecast
Based on 18 Wall Street analysts offering 12 month price targets for JAZZ in the last 3 months.
Highest
Current ၂၁၅.၁၁ US$
၃၃၇.၀၀ US$ (+၅၆.၆၆%)
Average
၂၉၈.၁၇ US$ (+၃၈.၆၁%)
Lowest
၂၂၉.၀၀ US$ (+၆.၄၆%)
Analyst
Recommendation
Action
Price target
Projected
Date
Geoff Meacham
Citi
Buy
Maintained
၃၂၅.၀၀ US$
+၅၁.၁%
10/15/2026
Etzer Darout
Barclays
Buy
Maintained
၂၇၁.၀၀ US$
+၂၆%
10/13/2026
Jason Gerberry
Bank of America Securities
Buy
Maintained
၃၁၃.၀၀ US$
+၄၅.၅%
10/09/2026
Leonid Timashev
RBC Capital
Buy
Maintained
၂၉၆.၀၀ US$
+၃၇.၆%
10/08/2026
Gregory Renza
Truist Financial
Buy
Maintained
၂၈၆.၀၀ US$
+၃၃%
10/07/2026
David Amsellem
Piper Sandler
Buy
Reiterated
၃၁၀.၀၀ US$
+၄၄.၁%
09/28/2026
Jeffrey Walch
Bernstein
Hold
Maintained
၂၂၉.၀၀ US$
+၆.၅%
09/25/2026
Andrea Newkirk
Goldman Sachs
Buy
Initiated
၃၃၇.၀၀ US$
+၅၆.၇%
09/24/2026
Ashwani Verma
UBS
Buy
Reiterated
၃၃၇.၀၀ US$
+၅၆.၇%
09/14/2026
Gary Nachman
Canaccord Genuity
Buy
Maintained
၃၀၀.၀၀ US$
+၃၉.၅%
08/31/2026
Joseph Thome
TD Cowen
Buy
Maintained
၃၀၀.၀၀ US$
+၃၉.၅%
08/31/2026
Ami Fadia
Needham
Buy
Reiterated
၃၁၀.၀၀ US$
+၄၄.၁%
08/31/2026
Sean Laaman
Morgan Stanley
Buy
Reiterated
၃၂၂.၀၀ US$
+၄၉.၇%
08/26/2026
David Hoang
Deutsche Bank
Buy
Maintained
၃၀၀.၀၀ US$
+၃၉.၅%
08/26/2026
Mohit Bansal
Wells Fargo
Buy
Maintained
၃၀၀.၀၀ US$
+၃၉.၅%
08/10/2026
Annabel Samimy
Stifel Nicolaus
Buy
Reiterated
၂၇၅.၀၀ US$
+၂၇.၈%
08/04/2026
Jessica Fye
J.P. Morgan
Buy
Reiterated
၂၇၆.၀၀ US$
+၂၈.၃%
08/04/2026
Brian Skorney
Robert W. Baird
Buy
Maintained
၂၈၀.၀၀ US$
+၃၀.၂%
08/04/2026
Unknown Analyst
Jefferies
Buy
Maintained
၂၈၂.၀၀ US$
+၃၁.၁%
07/13/2026
Joon Lee
Truist Financial
Buy
Initiated
၂၅၆.၀၀ US$
+၁၉%
06/09/2026
Unknown Analyst
Bernstein
Hold
Maintained
-
-
06/01/2026
Unknown Analyst
J.P. Morgan
Buy
Maintained
၂၆၅.၀၀ US$
+၂၃.၂%
05/20/2026
Tiago Fauth
Raymond James
Buy
Maintained
၂၃၉.၀၀ US$
+၁၁.၁%
05/06/2026
Unknown Analyst
Raymond James
Buy
Maintained
၂၃၉.၀၀ US$
+၁၁.၁%
05/06/2026
Last report
၂၀၂၆ ဩ ၃
Fiscal period
Q2 2026
၅.၇၁ US$ / ၆.၁၈ US$
-၇.၅၄%miss
Revenue / Est. (USD)
၁၂၀.၈၃ ဋေ / ၁၁၁.၄၄ ဋေ
+၈.၄၃%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၁၁၂.၆၁ ဋေ
၁၁၉.၇၉ ဋေ
၁၀၆.၈၉ ဋေ
၁၂၀.၈၃ ဋေ
Cost of goods sold
၁၂.၈၉ ကုဋေ
၁၁.၂၉ ကုဋေ
၉.၆၆ ကုဋေ
၁၁.၆၄ ကုဋေ
Cost of revenue
၁၂.၈၉ ကုဋေ
၁၁.၂၉ ကုဋေ
၉.၆၆ ကုဋေ
၁၁.၆၄ ကုဋေ
Research and development expenses
၁၉.၈၂ ကုဋေ
၁၇.၂၇ ကုဋေ
၁၉.၆၀ ကုဋေ
၂၀.၇၅ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃၇.၉၁ ကုဋေ
၄၁.၈၅ ကုဋေ
၃၅.၂၇ ကုဋေ
၃၈.၉၂ ကုဋေ
Operating expense
၇၄.၅၇ ကုဋေ
၇၆.၀၉ ကုဋေ
၇၂.၁၀ ကုဋေ
၇၆.၆၇ ကုဋေ
Total operating expenses
၈၇.၄၆ ကုဋေ
၈၇.၃၈ ကုဋေ
၈၁.၇၆ ကုဋေ
၈၈.၃၁ ကုဋေ
Operating income
၂၅.၁၅ ကုဋေ
၃၂.၄၁ ကုဋေ
၂၅.၁၃ ကုဋေ
၃၂.၅၂ ကုဋေ
Other non operating income
-
-
၁၂.၂၈ ကုဋေ
-
EBT including unusual items
၈.၉၉ သန်း
၂၀.၈၄ ကုဋေ
၂၉.၉၂ ကုဋေ
၂၁.၀၉ ကုဋေ
EBT excluding unusual items
၂၀.၃၀ ကုဋေ
၂၇.၈၀ ကုဋေ
၃၃.၆၇ ကုဋေ
၂၈.၇၉ ကုဋေ
Income tax expense
-၂၄.၂၄ ကုဋေ
၄.၉၆ သန်း
၆.၁၀ သန်း
၁.၈၁ ကုဋေ
Effective tax rate
-၂,၆၉၇.၂၀%
၂.၃၈%
၂.၀၄%
၈.၅၈%
Other operating expenses
-
-
-
-
Net income
၂၅.၁၄ ကုဋေ
၂၀.၃၅ ကုဋေ
၂၉.၃၁ ကုဋေ
၁၉.၂၈ ကုဋေ
Net profit margin
၂၂.၃၃%
၁၆.၉၈%
၂၇.၄၂%
၁၅.၉၆%
Earnings per share
၈.၁၃
၆.၆၄
၆.၃၄
၅.၇၁
Interest and investment income
၁.၈၆ ကုဋေ
၂.၀၅ ကုဋေ
၂.၃၄ ကုဋေ
၂.၅၃ ကုဋေ
Interest expense
-၆.၇၂ ကုဋေ
-၆.၅၉ ကုဋေ
-၆.၃၃ ကုဋေ
-၆.၂၄ ကုဋေ
Net interest expenses
-၄.၈၆ ကုဋေ
-၄.၅၄ ကုဋေ
-၃.၉၉ ကုဋေ
-၃.၇၁ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၄၂.၉၈ ကုဋေ
၅၀.၃၃ ကုဋေ
၄၃.၂၇ ကုဋေ
၅၀.၄၃ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ